Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

885 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Look beyond the plasma cells in immunocompromised patients.
Lécuyer R, Daniau B, Guelib I, Wilhelm N, Caudrelier L, Gauthier M. Lécuyer R, et al. Among authors: gauthier m. Int J Lab Hematol. 2022 Oct;44(5):815-816. doi: 10.1111/ijlh.13823. Epub 2022 Mar 6. Int J Lab Hematol. 2022. PMID: 35253398 No abstract available.
Incident users of tyrosine kinase inhibitors in patients with chronic myeloid leukemia: Analysis of anticancer treatment trajectories-A French population-based study using the French national health data system.
Vabre C, Zelmat Y, Gauthier M, Pajiep M, Conte C, Lapeyre-Mestre M, Dray-Spira R, Zureik M, Despas F. Vabre C, et al. Among authors: gauthier m. Am J Hematol. 2022 Aug;97(8):E307-E309. doi: 10.1002/ajh.26621. Epub 2022 Jun 7. Am J Hematol. 2022. PMID: 35617101 Free article. No abstract available.
"Accelerated phase" chronic lymphocytic leukemia: Still an intermediate risk disease in the era of targeted therapies.
Lapierre L, Syrykh C, Largeaud L, Cabarrou B, Filleron T, Oberic L, Kanoun S, Coster L, Laurent C, Branco B, Gadaud N, Récher C, Brechemier D, Balardy L, Vergez F, Ysebaert L, Gauthier M. Lapierre L, et al. Among authors: gauthier m. Hematol Oncol. 2022 Oct;40(4):805-808. doi: 10.1002/hon.2985. Epub 2022 Mar 8. Hematol Oncol. 2022. PMID: 35246868 No abstract available.
885 results